Back HIV Treatment

HIV Treatment

ASM Microbe 2016: PRO-140 Antibody Injections Maintain Viral Suppression Off ART

Subcutaneous injections of PRO 140, a monoclonal antibody that blocks HIV entry into cells, was well-tolerated and maintained undetectable viral load for more than a year after stopping antiretroviral therapy (ART) in patients with viral suppression, according to a study presented at the ASM Microbe 2016 meeting this week in Boston.

alt

Read more:

Big Increase in Proportion of HIV+ People with Viral Suppression in US

The proportion of people living with HIV receiving care in the U.S. who accessed antiretroviral therapy (ART) and achieved viral suppression increased substantially between 2009 and 2013, according to research published in the May 20 online edition of AIDS.

alt

Read more:

World Health Assembly Adopts Strategies for HIV, Viral Hepatitis, and STIs

The 194 member states participating in the 69th World Health Assembly, which governs the World Health Organization (WHO) in late May unanimously approved the adoption of WHO's draft global health sector strategies for management of HIV, viral hepatitis, and sexually transmitted infections (STIs) through the year 2021.

alt

Read more:

Starting HIV Treatment at First Clinic Visit After Diagnosis Improves Outcomes

A South African program aimed at shortening the usual process of HIV diagnosis, counseling, and preparation for antiretroviral therapy (ART) led to more people initiating treatment and achieving viral suppression, according to findings from the RapIT study published in the May 10 edition of PLoS Medicine.

alt

Read more:

amfAR Announces New Round of HIV Cure Research Grants

This month amfAR, the Foundation for AIDS Research, announced that it has granted 7 awards for research on HIV persistence, the understanding of which could lead to new approaches to an HIV cure -- part of the organization's Countdown to a Cure for AIDS initiative.

alt

Read more: